top of page

Fridays Case Study

Scaling a Telehealth Brand with Expert, Science-Backed Content

Customer

Cytena_edited.png

Description

Fridays is a telehealth platform delivering safe, clinically backed treatments for weight management, hormone health, and longevity, combining expert care with modern convenience.

Improved Compliance Readiness

Increased User Engagement with Educational Content

“Dan and the Co-Labb team delivered exactly what we needed: fast, accurate, and high-quality content that elevated our brand. The white papers are science-backed, visually polished, and incredibly valuable across our site and channels. Their PhD team brought credibility to everything they touched, and their hands-on support, from writing to strategy, has been a huge asset as we scale. Highly recommend.”

Sina Arham, CEO & Founder, Fridays Health


The Client


Fridays is a direct-to-consumer telehealth platform delivering modern, evidence-based solutions for hormonal and metabolic health. With a product line focused on compounds like Semaglutide and Testosterone, Fridays is shaping a new era of accessible, data-driven healthcare for consumers.



The Challenge


As Fridays gained traction in a growing market, the need to establish authority and scientific credibility became critical. Their team knew that high-quality white papers could play a vital role in building customer trust and satisfying compliance requirements.


However, with limited in-house bandwidth and tight deadlines, producing medically robust, visually polished white papers internally wasn’t feasible. Fridays needed a partner who could step in and deliver a complete, hands-off solution; fast.



"As a fast-growing telehealth brand, we needed science-backed content to build trust and meet compliance standards. With limited in-house resources, we couldn’t produce the quality or volume of white papers we needed, especially on a tight timeline."

Why Fridays Chose Co-Labb


Fridays turned to Co-Labb for our scientific depth, end-to-end support, and track record of helping digital health brands scale with credible content. Our content was expected to do more than educate, it needed to meet regulatory expectations, convert users, and align with Fridays’ brand voice. Their team trusted Co-Labb to deliver a blend of scientific accuracy and consumer relevance.


"We were impressed by Co-Labb’s all-PhD writing team. Their scientific expertise gave us instant credibility and confidence. They weren’t just writers, they understood the data. The credibility that comes from working with a team of PhDs was a key factor for us, and it’s exactly what our audience expects."

Sina Arham, CEO & Founder, Fridays Health



The Solution

Co-Labb provided a full white paper content service, from scientific research and clinical literature review through to writing, graphic design, and delivery.


We developed five white papers covering Fridays’ core offerings:


  • NAD+

  • Semaglutide

  • Sermorelin

  • Testosterone

  • Tirzepatide


Each paper was built to demonstrate product safety and efficacy, offering readers clinical insight without sacrificing readability. We also ensured visual consistency and polish for multi-channel use.


Importantly, Co-Labb didn’t stop at the content brief. We proactively audited Fridays’ website and product landing pages to align their messaging with the scientific standards of the white papers, strengthening consistency across their marketing and customer experience


"Co-Labb delivered five expertly written white papers end-to-end, turning complex clinical data into engaging, compliant content. What really stood out was how they went beyond the brief, they proactively audited our product landing pages and marketing copy to ensure all messaging aligned with the white paper content and upheld the same scientific standard. Their support has been a real asset as we grow."

Sina Arham, CEO & Founder, Fridays Health




A Private Training for Biotech, Pharma & Healthcare Teams: 

How To Transform Complex Science Into Content That Converts




The Results

The white papers are now a foundational element across Fridays’ digital ecosystem, helping drive engagement, build authority, and support compliance.


Key Outcomes:


  • Centralised library of science-backed content

  • Increased customer trust and content engagement

  • Improved alignment between marketing and medical messaging

  • Enhanced confidence in regulatory communications


"The white papers have become core content across our site, improving customer trust, increasing engagement, and helping support compliance reviews. They’ve strengthened both our brand and our internal confidence in the science we present."

Sina Arham, CEO & Founder, Fridays Health


Message from the Co-Labb Team


"Working with Sina on this project was genuinely refreshing. His vision for the brand and strong medical background meant he knew exactly what was needed to bring it to life, and trusted us to deliver it. It was clear from the start that we were the right fit to help Fridays grow with credibility and confidence."


Dan Sheridan, Founder, Co-Labb



​Industry:

Telehealth | Health & Wellness

Company Size:

SME

Working with Co-Labb since:

2025

Services Utilised:

Medical Copywriting, White Paper Development

Why Fridays Chose Co-Labb

Fridays turned to Co-Labb for our scientific depth, end-to-end support, and track record of helping digital health brands scale with credible content. Our content was expected to do more than educate, it needed to meet regulatory expectations, convert users, and align with Fridays’ brand voice. Their team trusted Co-Labb to deliver a blend of scientific accuracy and consumer relevance.

ModernVivo Case Study

From Website Launch to Leadership: Building Authority with Science-Driven Content

Co-Labb partnered with ModernVivo to deliver a full website copy, white papers, blogs, and social media content, building trust, establishing authority, and enabling consistent, high-quality content creation.

Blue Horizon International Case Study

Co-Labb Supports Blue Horizon International’s FDA Pre-IND Submission with Regulatory Writing

Blue Horizon International partnered with Co-Labb for end-to-end support in their Pre-IND submission to the FDA.

Cytiva Case Study

Driving Global Engagement with Drug Discovery Labs Through Strategic Content Creation

Cytiva, a leading name in life sciences and part of the Fortune 500 Danahar Corporation, provides essential tools and expertise to support biopharma discovery and manufacturing.

Relevant Case Studies

Petri Dish

Ready to Build Trust with Science-Driven Content?

Whether you need white papers, product education, or strategic content support, our PhD-level team helps health and wellness brands grow through credible, impactful content.

Book a discovery call to explore how Co-Labb can support your next launch.

bottom of page